Results
3050
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3050 companies
Nirvana Life Sciences
Market Cap: CA$410.0k
Engages in the research and development of therapeutic products to address addiction.
NIRV
CA$0.085
7D
0%
1Y
-88.7%
Mosaic ImmunoEngineering
Market Cap: US$5.7m
A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.
CPMV
US$0.79
7D
97.2%
1Y
-20.7%
Biomind Labs
Market Cap: US$1.2m
A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.
BMND.F
US$0.016
7D
0%
1Y
-93.3%
GlobeStar Therapeutics
Market Cap: US$1.2k
A clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States.
GSTC
US$0.000001
7D
0%
1Y
-99.8%
Sirona Biochem
Market Cap: CA$15.8m
A cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France.
SBM
CA$0.06
7D
0%
1Y
9.1%
Provectus Biopharmaceuticals
Market Cap: US$31.0m
A clinical-stage biotechnology company, engages in developing immunotherapy medicines for various diseases in the United States.
PVCT
US$0.073
7D
-9.4%
1Y
-35.4%
NKGen Biotech
Market Cap: US$10.7m
A clinical-stage biotechnology company, develops cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells.
NKGN
US$0.15
7D
13.2%
1Y
-81.5%
WEED
Market Cap: US$6.1m
Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.
BUDZ
US$0.038
7D
5.8%
1Y
-24.5%
Jolt Health
Market Cap: CA$572.8k
Operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.
JOLT
CA$0.09
7D
0%
1Y
n/a
Actavia Life Sciences
Market Cap: US$7.7m
A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.
RASP
US$0.01
7D
0%
1Y
n/a
Zelira Therapeutics
Market Cap: AU$4.5m
A biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States.
ZLD
AU$0.38
7D
-8.5%
1Y
-46.4%
Lionco Pharmaceutical GroupLtd
Market Cap: CN¥4.1b
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, research and development, production, sales and medical services in China.
603669
CN¥5.80
7D
-3.0%
1Y
29.2%
Zhejiang Hisoar Pharmaceutical
Market Cap: CN¥9.8b
Engages in the manufacture of pharmaceutical products and dyes in China and internationally.
002099
CN¥6.19
7D
2.0%
1Y
14.4%
Beijing Hotgen Biotech
Market Cap: CN¥15.7b
Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.
688068
CN¥176.60
7D
-5.5%
1Y
632.2%
Pyridam Farma
Market Cap: Rp5.5t
Engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.
PYFA
Rp490.00
7D
-19.7%
1Y
250.0%
KUKJEON PHARMACEUTICAL
Market Cap: ₩204.4b
Operates as a chemical total solutions provider in South Korea.
A307750
₩4,090.00
7D
3.7%
1Y
-0.7%
Hainan Haiyao
Market Cap: CN¥7.7b
Manufactures and sells pharmaceutical products and medical devices in China and internationally.
000566
CN¥5.92
7D
0.2%
1Y
45.1%
Tien Liang BioTech
Market Cap: NT$1.6b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
4127
NT$34.20
7D
-0.1%
1Y
-10.0%
Tibet Duo Rui Pharmaceutical
Market Cap: CN¥3.5b
Engages in the research and development, production, and sale of chemical pharmaceutical preparations and its raw materials in China.
301075
CN¥43.77
7D
14.6%
1Y
154.3%
Biome Grow
Market Cap: CA$562.1k
Focuses on the cannabis business.
BIO
CA$0.005
7D
0%
1Y
-50.0%
ChitogenX
Market Cap: CA$415.6k
An orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada.
CHGX
CA$0.005
7D
0%
1Y
-75.0%
Optimi Health
Market Cap: CA$22.2m
Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.
OPTI
CA$0.26
7D
13.3%
1Y
-19.0%
Nasus Pharma
Market Cap: US$72.3m
Operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions.
NSRX
US$8.01
7D
-1.1%
1Y
n/a
Agentix
Market Cap: US$1.2m
A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.
AGTX
US$0.032
7D
1.8%
1Y
-64.9%
Curative Biotechnology
Market Cap: US$8.5m
A development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices for patients with rare diseases.
CUBT
US$0.0093
7D
5.0%
1Y
-29.3%
BioNxt Solutions
Market Cap: CA$114.1m
Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.
BNXT
CA$0.92
7D
-9.8%
1Y
360.0%
Nymox Pharmaceutical
Market Cap: US$4.8m
A biopharmaceutical company, engages in the research and development of products for the aging population.
NYMX.F
US$0.043
7D
-28.3%
1Y
-69.3%
Ildong Pharmaceutical
Market Cap: ₩668.6b
Develops, manufactures, and sells pharmaceutical products in South Korea.
A249420
₩21,650.00
7D
-5.0%
1Y
59.1%
OliX Pharmaceuticals
Market Cap: ₩1.9t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩93,100.00
7D
21.9%
1Y
452.9%
Foresee Pharmaceuticals
Market Cap: NT$12.9b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$83.60
7D
4.5%
1Y
5.7%
Zhejiang Shapuaisi PharmaceuticalLtd
Market Cap: CN¥3.2b
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
603168
CN¥8.44
7D
1.8%
1Y
32.5%
Mycenax Biotech
Market Cap: NT$7.8b
Provides biopharmaceutical services and solutions for drug development and production in Taiwan.
4726
NT$37.80
7D
-3.6%
1Y
-17.5%
WPD Pharmaceuticals
Market Cap: CA$324.8k
Does not have any significant operations.
WBIO
CA$0.07
7D
0%
1Y
-44.0%
SOHM
Market Cap: US$4.4m
Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.
SHMN
US$0.0015
7D
-11.4%
1Y
19.2%
Curatis Holding
Market Cap: CHF 55.7m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 11.15
7D
-3.9%
1Y
59.3%
NovAccess Global
Market Cap: US$12.4k
A biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States.
XSNX
US$0.0002
7D
-33.3%
1Y
-97.3%